S&CO Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.28M Hold
10,050
0.21% 90
2025
Q1
$2.71M Buy
10,050
+4,300
+75% +$1.16M 0.18% 100
2024
Q4
$1.35M Hold
5,750
0.09% 124
2024
Q3
$1.58M Hold
5,750
0.1% 125
2024
Q2
$1.4M Hold
5,750
0.1% 127
2024
Q1
$859K Buy
+5,750
New +$859K 0.06% 142